This is a placebo-controlled study designed to learn if levetiracetam is effective for tardive dyskinesia.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
50
Connecticut Mental Health Center
New Haven, Connecticut, United States
Abnormal Involuntary Movement Scale (AIMS) Total Score
Time frame: 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.